 SAINT LAURENT, Quebec, May 14, 2021 GLOBE NEWSWIRE -- IntelGenx Technologies Corp. TSX-V:IGX OTCQB:IGXT IntelGenx, a leader in pharmaceutical films, today reported that the previously announced US12,346,300 investment in IntelGenx by ATAI Life Sciences AG atai has been completed. As a result of the investment, atai now holds approximately 25 of the issued and outstanding common stock of IntelGenx. 